Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LAB

Standard BioTools Inc

May 26 • 04:00PM ET

1.09

+0.06 5.83 %

Healthcare • Medical Devices • USA • Small • NASD

Peers: QTRX TXG BRKR RVTY ILMN

| Held by: VTI IWM VXF IBB IWN SCHA VTWO IWC VHT ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.24	Insider Own	1.74%	Shs Outstand	390.14M	Perf Week	10.20%
Market Cap	425.50M	Forward P/E	-	EPS next Y	-0.09	Insider Trans	5.43%	Shs Float	383.56M	Perf Month	21.18%
Enterprise Value	-0.19M	PEG	-	EPS next Q	-0.01	Inst Own	76.10%	Short Float	3.08%	Perf Quarter	-5.22%
Income	-94.08M	P/S	4.93	EPS this Y	33.33%	Inst Trans	-1.20%	Short Ratio	4.63	Perf Half Y	-14.84%
Sales	86.25M	P/B	0.76	EPS next Y	15.00%	ROA	-8.22%	Short Interest	11.82M	Perf YTD	-14.84%
Book/sh	1.44	P/C	0.93	EPS next 5Y	19.57%	ROE	-9.86%	52W High	1.72 -36.63%	Perf Year	18.27%
Cash/sh	1.17	P/FCF	-	EPS past 3/5Y	56.76% 23.22%	ROIC	-16.08%	52W Low	0.87 25.27%	Perf 3Y	-56.22%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-4.49% -9.19%	Gross Margin	48.30%	Volatility	5.04% 4.93%	Perf 5Y	-81.08%
Dividend TTM	-	EV/Sales	-0.00	EPS Y/Y TTM	31.01%	Oper. Margin	-91.02%	ATR (14)	0.05	Perf 10Y	-88.50%
Dividend Ex-Date	-	Quick Ratio	11.92	Sales Y/Y TTM	-49.17%	Profit Margin	-109.08%	RSI (14)	66.03	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	12.36	EPS Q/Q	-69.33%	SMA20	10.21%	Beta	1.36	Target Price	1.55
Payout	-	Debt/Eq	0.05	Sales Q/Q	-48.17%	SMA50	14.15%	Rel Volume	0.93	Prev Close	1.03
Employees	389	LT Debt/Eq	0.04	Earnings	May 05 AMC	SMA200	-10.73%	Avg Volume	2.56M	Price	1.09
IPO	Feb 10, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.35% 18.80%	Trades		Volume	2,317,379	Change	5.83%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-25	Downgrade	TD Cowen	Buy → Hold	$1.55
Feb-27-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-16-24	Initiated	TD Cowen	Buy	$3.50
Apr-04-24	Initiated	Jefferies	Buy	$3.25
Jul-12-23	Initiated	KeyBanc Capital Markets	Overweight	$4

May-05-26 05:38PM	Standard BioTools: Q1 Earnings Snapshot (Associated Press)
04:05PM	Standard BioTools Reports First Quarter 2026 Financial Results (GlobeNewswire)
Apr-21-26 07:00AM	Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026 (GlobeNewswire)
Feb-24-26 04:34PM	Standard BioTools: Q4 Earnings Snapshot (Associated Press Finance)
04:10PM	Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
07:00AM	Loading…
Feb-10-26 07:00AM	Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 (GlobeNewswire)
Jan-30-26 09:09AM	Standard BioTools Completes Sale of SomaLogic to Illumina (GlobeNewswire)
Jan-08-26 07:00AM	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue (GlobeNewswire) +20.31%
Nov-19-25 11:30AM	Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry (Business Wire)
Nov-10-25 12:15PM	Illumina Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks (PR Newswire)
Nov-04-25 05:31PM	Standard BioTools: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Standard BioTools Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-03-25 08:01AM	Earnings To Watch: Standard BioTools Inc (LAB) Reports Q3 2025 Result (GuruFocus.com)
Oct-21-25 07:00AM	Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025 (GlobeNewswire)
Sep-03-25 09:15AM	Illumina Protein Prep launches to drive greater proteomic insights for improved drug discovery and development (PR Newswire)
07:00PM	Loading…
Aug-11-25 07:00PM	Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:09PM	Standard BioTools: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-08-25 09:25AM	What to Expect from Standard BioTools Inc (LAB) Q2 2025 Earnings (GuruFocus.com)
Aug-07-25 05:30PM	Doximity (DOCS) Q1 Earnings and Revenues Top Estimates (Zacks)
Aug-06-25 07:00AM	Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study (GlobeNewswire)
Jul-21-25 07:00AM	Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 (GlobeNewswire)
Jun-26-25 08:07AM	Illumina Stock May Benefit From New Agreement to Acquire SomaLogic (Zacks)
Jun-25-25 12:16AM	Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (PR Newswire)
Jun-23-25 07:13AM	Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (PR Newswire) +17.14%
07:05AM	Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina (GlobeNewswire)
06:58AM	Illumina to buy SomaLogic for up to $425M (MedTech Dive)
May-30-25 07:00AM	Standard BioTools to Host Inaugural "Proteomics Roundtable" Webcast Series (GlobeNewswire)
May-09-25 05:00PM	Labrador Gold Announces Resignation of Director Kai Hoffmann (GlobeNewswire) +8.41%
May-07-25 08:26AM	Q1 2025 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
03:20AM	Loading…
03:20AM	Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-06-25 05:15PM	Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -7.83%
04:01PM	Standard BioTools Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-05-25 10:10AM	Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-24-25 07:00AM	Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 (GlobeNewswire)
Apr-22-25 04:05PM	Sight Sciences Appoints Gary Burbach to its Board of Directors (GlobeNewswire) +6.72%
07:00AM	Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 (GlobeNewswire)
Feb-27-25 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire) -10.68%
07:09AM	Q4 2024 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents)
02:22AM	Standard BioTools Inc (LAB) Q4 2024 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
Feb-26-25 06:52PM	Standard BioTools: Q4 Earnings Snapshot (Associated Press Finance) -7.14%
04:01PM	Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-25-25 10:54AM	Standard BioTools Inc (LAB) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com) -5.26%
Feb-12-25 07:00AM	Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025 (GlobeNewswire)
Jan-13-25 07:00AM	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue (GlobeNewswire) +26.38%
Jan-08-25 07:00AM	Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine (GlobeNewswire)
Dec-19-24 08:00AM	Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-07-24 08:00AM	Standard BioTools Appoints Alex Kim as Chief Financial Officer (GlobeNewswire)
Oct-31-24 11:00AM	Standard BioTools Inc (LAB) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... (GuruFocus.com)
08:01AM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-30-24 05:20PM	Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.43%
04:15PM	Standard BioTools: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-21-24 09:03PM	Millennium Management LLC Acquires Shares in Standard BioTools Inc (GuruFocus.com)
Oct-16-24 08:00AM	Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024 (GlobeNewswire)
Oct-03-24 04:56AM	Is Standard BioTools Inc. (LAB) the Best NASDAQ Stock Under $5? (Insider Monkey)
Sep-24-24 08:00AM	Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan 11K Platform (GlobeNewswire) +5.35%
Sep-18-24 08:00AM	Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH) (GlobeNewswire)
Aug-26-24 08:00AM	Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-23-24 06:03PM	Appian, Bitfarms, Standard BioTools, and More Stocks See Action From Activist Investors (Barrons.com) +9.74%
Aug-06-24 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-01-24 09:14AM	Q2 2024 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) -36.61%
Jul-31-24 09:57PM	LAB Stock Earnings: Standard BioTools Reported Results for Q2 2024 (InvestorPlace)
05:40PM	Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:36PM	Standard BioTools: Q2 Earnings Snapshot (Associated Press Finance)
04:02PM	Standard BioTools Announces Senior Leadership Changes (GlobeNewswire)
04:01PM	Standard BioTools Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-17-24 08:01AM	Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024 (GlobeNewswire)
May-28-24 04:01PM	Standard BioTools Purchases the Carterra LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers (GlobeNewswire)
May-22-24 04:01PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-20-24 08:00AM	Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-13-24 10:45AM	Standard BioTools Inc. (NASDAQ:LAB) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:59PM	LAB Stock Earnings: Standard BioTools Reported Results for Q1 2024 (InvestorPlace) -5.49% +7.59%
04:33PM	Standard BioTools: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 11:27AM	Standard BioTools Initiates Restructuring Plan With 10% Workforce Reduction (MT Newswires)
08:01AM	Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth (GlobeNewswire)
08:00AM	Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire)
Apr-08-24 08:00AM	Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging (GlobeNewswire) +5.11%
Apr-03-24 04:01PM	Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan Platform for Translational Medicine Research (GlobeNewswire)
Mar-18-24 08:12AM	Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock (GlobeNewswire)
Mar-05-24 08:27AM	Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 06:29AM	Q4 2023 Standard BioTools Inc Earnings Call (Thomson Reuters StreetEvents) -5.06%
Feb-28-24 04:41PM	Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... (GuruFocus.com)
04:16PM	Standard BioTools: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 08:00AM	Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing (GlobeNewswire)
Feb-22-24 04:05PM	Standard BioTools to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-14-24 08:30AM	Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Feb-07-24 08:30AM	Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine (GlobeNewswire)
Jan-08-24 08:30AM	Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue (GlobeNewswire) +13.37%
Jan-05-24 08:46AM	Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools (GlobeNewswire)
Jan-04-24 10:23PM	Standard BioTools Stockholders Approve Merger with SomaLogic (GlobeNewswire) -5.39%
09:44PM	SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting (PR Newswire)
Dec-29-23 05:04PM	Glass Lewis Recommends Standard BioTools Stockholders Vote FOR All Proposals Relating to Proposed Merger with SomaLogic (GlobeNewswire)
Dec-28-23 04:16PM	Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools (PR Newswire) +5.45%
Dec-26-23 03:59PM	SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure (PR Newswire) +7.54%
Dec-22-23 06:57PM	ISS Recommends Standard BioTools Stockholders Vote FOR All Proposals Relating to Proposed Merger with SomaLogic (GlobeNewswire)
Dec-21-23 08:00AM	SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools (GlobeNewswire)
Dec-20-23 09:00AM	Skye Fund III Issues Letter Regarding Opposition to SomaLogic's Proposed Merger with Standard BioTools (GlobeNewswire) -8.10%

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.

PresidentDr. Michael Egholm Ph.D.

Chief Financial OfficerMr. Hanjoon Kim

Chief Business Officer & Senior VPMr. Sean Mackay

VP & Chief Accounting OfficerMr. Jonathan Mickelsen

Vice President of Investor RelationsJohn Graziano

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Egholm Michael	President & CEO	Apr 06 '26	Option Exercise	0.00	196,513	0	6,790,596	Apr 08 09:55 PM
Kim Hanjoon Alex	Chief Financial Officer	Apr 06 '26	Option Exercise	0.00	70,183	0	2,800,702	Apr 08 09:55 PM
Casdin Partners Master Fund, L	Director	Dec 04 '25	Buy	1.45	150,000	217,020	72,100,000	Dec 04 08:59 PM
Casdin Partners Master Fund, L	Director	Dec 02 '25	Buy	1.42	125,000	177,512	71,875,000	Dec 04 08:59 PM
Casdin Partners Master Fund, L	Director	Dec 03 '25	Buy	1.44	75,000	108,037	71,950,000	Dec 04 08:59 PM
Casdin Partners Master Fund, L	Director	Nov 25 '25	Buy	1.30	7,550,000	9,838,405	71,750,000	Nov 26 04:58 PM
Casdin Partners Master Fund, L	Director	Nov 24 '25	Buy	1.43	150,000	214,875	64,200,000	Nov 26 04:58 PM
Casdin Partners Master Fund, L	Director	Nov 20 '25	Buy	1.30	450,000	586,260	64,050,000	Nov 20 07:45 PM
Casdin Partners Master Fund, L	Director	Nov 19 '25	Buy	1.28	350,000	448,910	63,600,000	Nov 20 07:45 PM
Casdin Partners Master Fund, L	Director	Nov 18 '25	Buy	1.23	275,000	339,405	63,250,000	Nov 20 07:45 PM
Casdin Partners Master Fund, L	Director	Nov 13 '25	Buy	1.20	450,000	541,395	62,500,000	Nov 17 06:58 PM
Casdin Partners Master Fund, L	Director	Nov 14 '25	Buy	1.24	250,000	309,800	62,750,000	Nov 17 06:58 PM
Casdin Partners Master Fund, L	Director	Nov 17 '25	Buy	1.22	225,000	275,580	62,975,000	Nov 17 06:58 PM
Casdin Partners Master Fund, L	Director	Nov 12 '25	Buy	1.19	375,000	445,838	62,050,000	Nov 12 07:46 PM
Casdin Partners Master Fund, L	Director	Nov 11 '25	Buy	1.20	300,000	358,800	61,675,000	Nov 12 07:46 PM
Casdin Partners Master Fund, L	Director	Nov 10 '25	Buy	1.17	275,000	321,915	61,375,000	Nov 12 07:46 PM
Casdin Partners Master Fund, L	Director	Nov 07 '25	Buy	1.12	225,000	252,765	61,100,000	Nov 12 07:46 PM
Casdin Partners Master Fund, L	Director	Sep 09 '25	Buy	1.29	100,000	128,920	60,875,000	Sep 11 09:03 PM
Casdin Partners Master Fund, L	Director	Sep 04 '25	Buy	1.28	250,000	319,350	60,775,000	Sep 05 07:08 PM
Casdin Partners Master Fund, L	Director	Sep 03 '25	Buy	1.27	250,000	316,400	60,525,000	Sep 05 07:08 PM
Casdin Partners Master Fund, L	Director	Aug 22 '25	Buy	1.26	200,000	252,680	59,950,000	Aug 26 08:46 PM
Casdin Partners Master Fund, L	Director	Aug 25 '25	Buy	1.24	200,000	248,180	60,150,000	Aug 26 08:46 PM
Casdin Partners Master Fund, L	Director	Aug 26 '25	Buy	1.26	125,000	157,938	60,275,000	Aug 26 08:46 PM
Casdin Partners Master Fund, L	Director	Aug 15 '25	Buy	1.22	150,000	183,210	59,750,000	Aug 15 09:18 PM
Casdin Partners Master Fund, L	Director	Aug 14 '25	Buy	1.21	133,220	161,543	59,600,000	Aug 15 09:18 PM
Casdin Partners Master Fund, L	Director	Aug 13 '25	Buy	1.31	75,000	98,280	59,466,780	Aug 15 09:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LAB

Standard BioTools Inc

Upgrade your Finviz experience